Orally administered berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-γ and subsequent expression of HGF in colons
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference40 articles.
1. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats;Afzal;J. Physiol. Biochem.,2016
2. Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese;Alolga;Sci. Rep.,2016
3. Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis;Chakraborty;Expert Opin. Investig. Drugs,2013
4. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats;Chen;AAPS PharmSciTech,2011
5. Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications;Chen;Am. J. Chin. Med.,2014
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Purinergic P2X7 receptor involves in anti-retinal photodamage effects of berberine;Purinergic Signalling;2024-03-15
2. The Application of Berberine in Fibrosis and the Related Diseases;The American Journal of Chinese Medicine;2024-01
3. Berberine protects against sepsis-related acute lung injury in rats via PPAR-γ signaling pathway upregulation and improvement at the cellular level: Functional, biochemical, and immunohistochemistry study;General physiology and biophysics;2024
4. Berberine hydrochloride ameliorates PM2.5-induced pulmonary fibrosis in mice through inhibiting oxidative stress and inflammatory;Chemico-Biological Interactions;2023-12
5. A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective;Chinese Medicine;2023-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3